BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24917244)

  • 1. Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes.
    Kalamohan K; Periasamy J; Bhaskar Rao D; Barnabas GD; Ponnaiyan S; Ganesan K
    Mol Oncol; 2014 Oct; 8(7):1306-25. PubMed ID: 24917244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes.
    Balakrishnan K; Ganesan K
    Funct Integr Genomics; 2020 Nov; 20(6):813-824. PubMed ID: 32949316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer.
    Song WM; Lin X; Liao X; Hu D; Lin J; Sarpel U; Ye Y; Feferman Y; Labow DM; Walsh MJ; Zheng X; Zhang B
    Int J Cancer; 2020 Mar; 146(5):1268-1280. PubMed ID: 31463974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpressed modular gene expression reveals inverse correlation between immune responsive transcription and aggressiveness in gastric tumours.
    Kalamohan K; Rathinam D; Panneerpandian P; Ganesan K
    Cancer Immunol Immunother; 2017 Jul; 66(7):941-954. PubMed ID: 28405765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
    Kim TM; Ko YH; Ha SJ; Lee HH
    BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of gastric tumors with activated ERK/MAPK signaling cascades for the development of targeted therapeutics.
    Pandian J; Ganesan K
    Exp Cell Res; 2022 Jan; 410(1):112956. PubMed ID: 34864005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
    Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
    Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of oncogenic signaling pathways associated with the dimorphic metabolic dysregulations in gastric cancer subtypes.
    Balakrishnan K; Ganesan K
    Med Oncol; 2022 Jun; 39(9):132. PubMed ID: 35723749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juxtaposed genes in 7q21-22 amplicon contribute for two major gastric cancer sub-Types by mutual exclusive expression.
    Tamilzhalagan S; Muthuswami M; Ganesan K
    Mol Carcinog; 2017 Apr; 56(4):1239-1250. PubMed ID: 27805295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche.
    Hayakawa Y; Ariyama H; Stancikova J; Sakitani K; Asfaha S; Renz BW; Dubeykovskaya ZA; Shibata W; Wang H; Westphalen CB; Chen X; Takemoto Y; Kim W; Khurana SS; Tailor Y; Nagar K; Tomita H; Hara A; Sepulveda AR; Setlik W; Gershon MD; Saha S; Ding L; Shen Z; Fox JG; Friedman RA; Konieczny SF; Worthley DL; Korinek V; Wang TC
    Cancer Cell; 2015 Dec; 28(6):800-814. PubMed ID: 26585400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDX1/2 and KLF5 Expression and Epigenetic Modulation of Sonic Hedgehog Signaling in Gastric Adenocarcinoma.
    Samadani AA; Nikbakhsh N; Taheri H; Shafaee S; Fattahi S; Pilehchian Langroudi M; Hajian K; Akhavan-Niaki H
    Pathol Oncol Res; 2019 Jul; 25(3):1215-1222. PubMed ID: 30685841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of kinases and kinase inhibitors for the differential targeting of Wnt/β-catenin signaling in gastric cancer subtypes.
    Bhaskar Rao D; Devanandan HJ; Ganesan K
    Drug Dev Res; 2021 Dec; 82(8):1182-1192. PubMed ID: 34002415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplified 7q21-22 gene MCM7 and its intronic miR-25 suppress COL1A2 associated genes to sustain intestinal gastric cancer features.
    Tamilzhalagan S; Rathinam D; Ganesan K
    Mol Carcinog; 2017 Jun; 56(6):1590-1602. PubMed ID: 28059478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
    Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE
    Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide analysis of the oxyntic proliferative isthmus zone reveals ASPM as a possible gastric stem/progenitor cell marker over-expressed in cancer.
    Vange P; Bruland T; Beisvag V; Erlandsen SE; Flatberg A; Doseth B; Sandvik AK; Bakke I
    J Pathol; 2015 Dec; 237(4):447-59. PubMed ID: 26178168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition and gastric cancer stem cell.
    Xia P; Xu XY
    Tumour Biol; 2017 May; 39(5):1010428317698373. PubMed ID: 28459211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATOH1 Can Regulate the Tumorigenicity of Gastric Cancer Cells by Inducing the Differentiation of Cancer Stem Cells.
    Han ME; Baek SJ; Kim SY; Kang CD; Oh SO
    PLoS One; 2015; 10(5):e0126085. PubMed ID: 25950549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.
    Fan D; Ren B; Yang X; Liu J; Zhang Z
    J Exp Clin Cancer Res; 2016 Nov; 35(1):177. PubMed ID: 27846906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
    Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
    Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.